Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.
Summary
A00885, titled the "Equity in Fertility Treatment Act," would amend New York insurance law to broaden the definition of infertility and expand mandated health insurance coverage for in-vitro fertilization (IVF). The bill revises the infertility definition to include not only the traditional inability to conceive after a period of unprotected intercourse, but also a person’s inability to reproduce without medical intervention, and physician findings based on medical, sexual, reproductive history, age, physical findings, or diagnostic testing. It also clarifies that earlier evaluation and treatment may be appropriate in some cases.
The bill would require large group health insurance policies and contracts to cover IVF treatment for infertility, replacing the current reference to a limited number of IVF cycles with coverage for completed oocyte retrievals and unlimited embryo transfers from fresh or frozen oocytes or embryos from a covered retrieval. Coverage must follow American Society for Reproductive Medicine guidelines and use single embryo transfer when medically appropriate. The bill also states that coverage cannot be denied because a covered person participated in fertility services provided by or to a third party, and it allows standard deductibles, coinsurance, and copayments consistent with other benefits in the policy or contract.
Impact
The bill would amend sections 3221 and 4303 of the Insurance Law, affecting both large group policies and large group contracts delivered or issued in New York. Its practical effect would be to expand the scope of infertility treatment coverage required from insurers and health plans, likely increasing access to IVF and related fertility services for individuals and couples who meet the broadened infertility definition. It would also remove the prior cycle-based framing and replace it with a retrieval-and-transfer structure, which could change how insurers administer and authorize fertility benefits.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate or formal support/opposition in the available record. Based on the bill text and sponsor list, the measure appears to be framed as a patient-access and equity initiative aimed at reducing barriers to fertility treatment. The overall tone of the legislation is pro-coverage and pro-access, with an emphasis on aligning insurance rules with modern fertility care and medical guidance.
Contention
The main points of potential contention are the cost and scope of the mandated benefit, especially the shift to coverage for completed oocyte retrievals and unlimited embryo transfers rather than a limited number of IVF cycles. Insurers and employers may object to broader mandated coverage, while advocates are likely to support the expanded infertility definition, the inclusion of single individuals and people needing medical intervention, and the prohibition on denying coverage based on third-party fertility services. Another possible issue is how the superintendent would regulate deductibles and copayments, and how the medical-necessity standard would be applied in practice.
Same As
Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.
Same As
Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.